Cerevance is a new pharmaceutical company focused on central nervous system diseases.

Our strengths include a powerful technology platform, a pipeline of novel discovery-stage and clinical-stage compounds and a proven team. We believe that we are well positioned to deliver life-changing therapeutics for patients who have brain-related disorders while creating value for our employees and shareholders.